Clinical use of emerging therapies in relapsed or refractory follicular lymphoma

Clin Adv Hematol Oncol. 2020 Dec;18 Suppl 20(12):15-19.

Author

Lori A Leslie^{1

2

3}

Affiliations

¹ John Theurer Cancer Center, Hackensack, New Jersey.
² Mountainside Medical Center, Montclair, New Jersey.
³ Hackensack Meridian Health, Hackensack, New Jersey.

PMID: 33843896

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Humans
Lymphoma, Follicular* / diagnosis
Lymphoma, Follicular* / drug therapy
Recurrence
Rituximab / therapeutic use

Substances

Rituximab